SEC Form 4 · accession 0001235802-18-000084
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer S. Walker
Officer — SVP, Process Improvement
Period of report
Jun 26, 2018
Accepted (ET)
Jun 28, 2018 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jun 26, 2018 | M | 3,098 | $22.55 | A | 33,809 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jun 26, 2018 | M | 11,536 | $20.75 | A | 45,345 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jun 26, 2018 | M | 5,403 | $15.04 | A | 50,748 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jun 26, 2018 | M | 4,154 | $17.82 | A | 54,902 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jun 26, 2018 | M | 15,463 | $17.01 | A | 70,365 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F2 | Jun 26, 2018 | S | 42,654 | $26.0331 | D | 27,711 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $22.55 | Jun 26, 2018 | M | 3,098 | D | Oct 1, 2015 | Apr 17, 2023 | Ordinary Shares | 3,098 | 0 | D |
| Stock Option (right to buy) | $20.75 | Jun 26, 2018 | M | 11,536 | D | Oct 1, 2015 | May 9, 2022 | Ordinary Shares | 11,536 | 0 | D |
| Stock Option (right to buy) | $15.04 | Jun 26, 2018 | M | 5,403 | D | Oct 1, 2015 | May 11, 2021 | Ordinary Shares | 5,403 | 0 | D |
| Stock Option (right to buy) | $17.82 | Jun 26, 2018 | M | 4,154 | D | Oct 1, 2015 | May 13, 2020 | Ordinary Shares | 4,154 | 0 | D |
| Stock Option (right to buy) | $17.01 | Jun 26, 2018 | M | 15,463 | D | Oct 1, 2015 | Dec 11, 2019 | Ordinary Shares | 15,463 | 0 | D |
Explanation of responses
- F1These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2Includes 7,838 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 3,687 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.89 to $26.19, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.